List of pharmaceutical compound number prefixes

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

This list of pharmaceutical compound number prefixes details a pharmaceutical drug labeling standard. Pharmaceutical companies produce a large number of compounds, which cannot all be given names. Instead, they are systematically numbered for internal reference. The number is prefixed with a letter code indicating which company synthesized the compound. For example, CP-529414 is the compound number for the recently failed Pfizer experimental drug torcetrapib. If the company or its agents choose to publish information or research results about the drug before it has been assigned a generic name (such as an INN, USAN, or BAN), they will refer to it by this number.

A large list of code designations with corresponding trade names can be found in Appendix IV of the USP Dictionary.

There are three primary methods of prefixing the numeric identifier - with a space,[1] with nothing,[2][3] and most commonly with a dash.[4]

A to F[edit]

G to L[edit]

M to S[edit]

T to Z[edit]


  1. ^ a b "ArQule clinical pipeline". Retrieved 2016-09-16. 
  2. ^ a b "Regeneron PCSK9 Antibody REGN727". Archived from the original on 2012-04-16. Retrieved 2012-04-17. 
  3. ^ a b "Exelixis HSP90 inhibitor XL888". Retrieved 2016-09-16. 
  4. ^ a b "AbbVie pipeline, using ABBV- as prefix". Retrieved 2016-09-16. 
  5. ^ a b "AbbVie spun out of Abbott". Retrieved 2016-09-15. 
  6. ^ "ADL5747". Retrieved 2008-03-19. [dead link]
  7. ^ "Adventrx Product List". Archived from the original on 2007-11-16. Retrieved 2007-11-18. 
  8. ^ "Amgen goes 6-for-6 in Phase III". Retrieved 2014-11-25. 
  9. ^ "Antisense Therapeutics Ltd Home Page". Retrieved 2008-02-20. 
  10. ^ "Edison outlook report on YM Biosciences" (PDF). Retrieved 2016-09-19. 
  11. ^ "Eagle Pharmacy - Pharmaceutical Compounding". Retrieved 2016-04-26. 
  12. ^ a b "Genentech Pipeline". Retrieved 2016-09-29. 
  13. ^ "GDC-0152". American Chemical Society. Retrieved 2016-09-29. 
  14. ^ "GNE-272". American Chemical Society. 
  15. ^ "Neurocrine Vmat2 inhibitor NBI-98854". Archived from the original on 2015-01-30. Retrieved 2016-09-13. 
  16. ^ "Sunesis BTK inhibitor SNS-062". Retrieved 2016-09-15. 
  17. ^ "TH-302 clinical trial". Retrieved 2013-07-23. 
  18. ^ "MM&M News". Retrieved 2009-02-16. 
  19. ^ "TransMolecular Product Pipeline". Archived from the original on 2007-07-29. Retrieved 2007-11-18. 
  20. ^ "Taisho Press Release". Retrieved 2008-01-07. 
  21. ^ "UCL1684 at". Retrieved 2018-03-24. 
  22. ^ "UCL1684 at". Retrieved 2018-03-24.